Website search

We know that information provided through our Opening the Register service can be life-changing and understand that, where people have received conflicting information, this is distressing. These FAQs provide more information about these situations.

Fertility 2022 - Julia Chain, Chair of the HFEA delivers a speech: 'The HFEA 30 years on – what needs to change?' Saturday, 8th January 2022

The HFEA welcomes the publication of two papers in the New England Journal of Medicine, which details that eight babies have now been born through pioneering IVF technique that reduces the risk of mitochondrial diseases.

Julia Chair, HFEA Chair, has today delivered a speech. The HFEA is the first regulator of its kind in the world, and we are recognised as the global gold standard for innovative and effective regulation. While our 30th anniversary is a cause for celebration, it should also be a prompt for reflection.

Many children in the UK are conceived with the help of a donor. Without a donor, many parents wouldn't have been able to fulfil their wish to have a family.

Mitochondrial donation treatment can be used by people with severe mitochondrial disease to avoid passing the condition onto their children. This page introduces you to what the treatment involves and how you can apply to have it.

Health and Care Bill: changing the storage limits for human eggs, sperm and embryos

This policy outlines the ways the HFEA collects and uses personal data and sensitive personal data from patients and individuals who contact the HFEA.

On this page you will find summaries of embryo research projects currently taking place in the UK.